Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 8th:
AbbVie Inc. (ABBV - Free Report) : This developer and manufacturer of pharmaceutical products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.1% over the last 60 days.
AbbVie Inc. Price and Consensus
AbbVie’s shares gained 2.5% over the last one month more than S&P 500’s loss of -3.3%. The company possesses a Momentum Score of A.
AbbVie Inc. Price
Aduro BioTech, Inc. : This immunotherapy company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.7% over the last 60 days.
Aduro Biotech, Inc. Price and Consensus
Aduro BioTech’s shares gained 8.9% over the last one month. The company possesses a Momentum Score of A.
Aduro Biotech, Inc. Price
The Buckle Inc. (BKE - Free Report) : This apparel, footwear and accessories retailer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 60 days.
Buckle, Inc. (The) Price and Consensus
The Buckle’s shares gained 5.8% over the last one month. The company possesses a Momentum Score of B.
Buckle, Inc. (The) Price
AudioEye, Inc. (AEYE - Free Report) : This provider of Web accessibility solutions has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.9% over the last 60 days.
Audioeye, Inc. Price and Consensus
AudioEye’s shares gained 27.1% over the last one month. The company possesses a Momentum Score of A.
Audioeye, Inc. Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 8th:
AbbVie Inc. (ABBV - Free Report) : This developer and manufacturer of pharmaceutical products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.1% over the last 60 days.
AbbVie Inc. Price and Consensus
AbbVie’s shares gained 2.5% over the last one month more than S&P 500’s loss of -3.3%. The company possesses a Momentum Score of A.
AbbVie Inc. Price
Aduro BioTech, Inc. : This immunotherapy company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.7% over the last 60 days.
Aduro Biotech, Inc. Price and Consensus
Aduro BioTech’s shares gained 8.9% over the last one month. The company possesses a Momentum Score of A.
Aduro Biotech, Inc. Price
The Buckle Inc. (BKE - Free Report) : This apparel, footwear and accessories retailer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 60 days.
Buckle, Inc. (The) Price and Consensus
The Buckle’s shares gained 5.8% over the last one month. The company possesses a Momentum Score of B.
Buckle, Inc. (The) Price
AudioEye, Inc. (AEYE - Free Report) : This provider of Web accessibility solutions has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.9% over the last 60 days.
Audioeye, Inc. Price and Consensus
AudioEye’s shares gained 27.1% over the last one month. The company possesses a Momentum Score of A.
Audioeye, Inc. Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on BKE - FREE
Get the latest research report on ABBV - FREE
Get the latest research report on AEYE - FREE